Embecta Corp. (EMBC), a global diabetes care company, on Tuesday, reported financial results for the fiscal fourth quarter ended September 30, 2024, with net income and revenue exceeding consensus estimates. The company also announced a restructuring plan, to streamline operations.
Net income for the fiscal fourth quarter of 2024 was $14.6 million, or $0.25 per share, compared to $6.0 million, or $0.10 per share, in the same period last year.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com